Matthew Shair, Director at Nuvalent, Inc. (NUVL), sold 3,927 shares at $91.31 ($360K) on 2024-10-28, disclosed to the SEC on 2024-10-30.
Scheduled sale ($360k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.31 | 1,181 | $108K | 29.9% |
| 2 | $91.31 | 1,181 | $108K | 29.9% |
| 3 | $92.27 | 746 | $69K | 19.1% |
| 4 | $92.27 | 746 | $69K | 19.1% |
| 5 | $93.11 | 73 | $7K | 1.9% |
| Total | $91.71 avg | 3,927 |
| $360K |
| 100% |
| Filing → |
| NUVL | SELL | 2025-02-25 | $265K | — | Filing → |
| NUVL | SELL | 2025-01-29 | $302K | — | Filing → |
| NUVL | SELL | 2024-12-26 | $285K | — | Filing → |